Safety of CoronaVac and ChAdOx1 vaccines against SARS-CoV-2 in patients with rheumatoid arthritis: data from the Brazilian multicentric study safer
2024 · Advances in Rheumatology · 3 citations
https://doi.org/10.1186/s42358-024-00397-5
K
Ketty Lysie Libardi Lira Machado
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
112
Papers
150
Citations
6
h-index
4
i10-index
Ketty Lysie Libardi Lira Machado is an academic researcher from Universidade Federal do Espírito Santo. The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & Systemic Lupus Erythematosus Research & Systemic Sclerosis and Related Diseases. The author has an h-index of 6, co-authored 96 publications.
ORCID: 0000-0003-2545-6795Papers by this author
worksBrazilian recommendations for the management of tuberculosis infection in immune-mediated inflammatory diseases
2025 · Advances in Rheumatology · 3 citations
https://doi.org/10.1186/s42358-025-00449-4
Reply to the letter on “Brazilian guidelines for the management of tuberculosis infection in immune-mediated inflammatory diseases: is retesting in latent tuberculosis screening appropriate and safe?”
2025 · Advances in Rheumatology · 0 citations
https://doi.org/10.1186/s42358-025-00501-3
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat